Business Wire

Luxury Electric Aircraft Developer VRCO, Signs MOU with Spanish Firm CITD

Share

Luxury electric aircraft developer VRCO, has appointed Spanish firm CITD as its sole design and engineering partner, for the XP4 and XPC and agrees on manufacturing support, flight testing and regional representation for e-VTOL training.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220830005560/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

CITD (Head Office, Madrid) – VRCO Engagement Meeting

The two companies have agreed a design and engineering program for VRCO’s XP4 Electric Air Vehicle and XPC Cargo variant, which will also include the deployment of training hardware – essential because of the Xcraft XP4’s unique flight deck – and an e-VTOL curriculum.

CITD are seeking to maximise opportunities from the emergence of the new segment of electric aircraft.

“We are entering the ‘Age of Airvolution™’, and in the near future, learning to fly will be accessible, affordable and will provide a strong rewarding career”, Michael Smith, founder and CEO of VRCO said.

About CITD

CITD is an Aeronautics, Space, and Defense design, engineering, and manufacturing firm with 20 years of experience. CITD’s expertise resides in aerospace structures, electrical systems, and additive manufacturing. The company is also executing projects in the field of ZERO Emissions (All-electric and H2 Aviation and Sustainable Aircraft Fuel).

For more information on CITD, please visit www.citd.eu

About VRCO

VRCO Limited is an Aerospace company based in Derby, UK, developing the NeoXcraft e-VTOL aircraft and supporting services. VRCO was founded by Michael Smith to develop a novel fully electric vertical take-off and landing platform, the Xcraft. The initial Xcraft Feasibility and Power Optimisation Studies were undertaken by the Institute for Innovation in Sustainable Engineering (IISE). The company is now building its full-size prototype whilst supporting clients like ESR to prepare and lead in the Airvolution.

For more information on VRCO, please visit www.vrco.co.uk

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

VRCO
Investor Relations
Michael Smith
CEO & Founder
+44 7497650747
mike@vrco.co.uk

CITD
Investor Relations
Luis Iglesias
Business Development, Director
+34 692 691 402
luis.iglesias@citd.eu

Media
Jamie Ivory & Andy Bothwell
Performance Comms
Corporate Communications
+852 2376 9617
jamie@performancecomms.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Strong growth, but lower margins for Jotun6.10.2022 21:00:00 CEST | Press release

Jotun increased both operating revenue and operating profit year to date. However, the operating margin was challenged by high raw material prices and significant global unrest. Market status Increased sales volume and prices led to strong topline growth for Jotun during the first and second tertiary 2022. Operating revenue came in at NOK 18 243 million, up 22 per cent from the same period last year. All segments (Decorative Paints, Protective Coatings, Marine Coatings and Powder Coatings) delivered double-digit sales growth. “We are satisfied with the development. It is great to see that the marine newbuilding market has recovered after a difficult period. We also see sales improving within ship maintenance products, protective coatings and decorative paints,” President & CEO Morten Fon says. Global challenges The positive development comes in a time of major global challenges. The war in Ukraine is affecting the raw material markets and creating an energy crisis in Europe. In additio

ProDERM Study Results of octagam ® 10% Treatment in Patients With Dermatomyositis Published in the New England Journal of Medicine6.10.2022 18:33:00 CEST | Press release

Octapharma announced today the results from the ProDERM study on the efficacy and safety of octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in the New England Journal of Medicine (Aggarwal R et al. “Efficacy and safety of intravenous immunoglobulin in dermatomyositis”). Dermatomyositis is an immune-mediated myopathy characterised by chronic inflammation of the skin and muscles, leading to cutaneous rashes and progressive muscle weakness. DM is associated with increased morbidity and mortality due to muscle weakness and visceral involvement. Prior to the ProDERM study findings, no therapy had been approved in the US or Europe for the treatment of dermatomyositis based on randomized clinical trials. The Progress in DERMatomyositis (ProDERM) study was the first large randomized clinical trial to investigate an intravenous immunoglobulin (IVIg) (octagam® 10%) in dermatomyositis. The results of the study demonstrated that octaga

New Visa Reports Underscore Importance of Cybersecurity Amid Shifting Threats6.10.2022 17:34:00 CEST | Press release

Visa Inc. (NYSE:V), the world leader in digital payments, today shared an updated look at how fraud has evolved since the height of the pandemic, with criminals simultaneously targeting online and offline vulnerabilities as our daily lives return to a blend of in-person and e-commerce experiences. “As in-person commerce returns to pre-pandemic levels, crooks are back to exploiting the physical points of vulnerability in stores, while continuing to capitalize on e-commerce through malware, ransomware and phishing attacks, among others,” said Paul D. Fabara, Chief Risk Officer at Visa. “In fact, we are continuing to see high rates of skimming, growing over the already elevated levels of the winter of 2021, where fraudsters are jumping on the rise of in-person activity.” Two new pieces of research – the latest Visa Biannual Threats Report and an MIT Technology Review Insights study “Moving Money in a Digital World,” released today in partnership with Visa – highlight new and returning thr

Eurosets Presents Colibrì, the Lightest and Most Compact ECLS System in the Market Which May Be Transported Even in a Backpack6.10.2022 17:24:00 CEST | Press release

Eurosets, a company based in Medolla (Italy) leader in the development, production, and commercialization of advanced medical devices, announced during the 36th European Association for Cardiothoracic Surgery (EACTS) annual meeting (Milan, 5th-8th October 2022) the launch of Colibrì, the lightest extracorporeal life support (ECLS) system available in the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221003005921/en/ Ettore Sansavini, Eurosets President, and Antonio Petralia, Eurosets CEO, next to the Colibrì (Photo: Business Wire) Colibrì complements and expands Eurosets ECLS portfolio with the objective to provide temporary support to patients suffering from ventricular failure, cardiac arrest, or respiratory failure in a variety of different applications, including extracorporeal membrane oxygenation (ECMO), extracorporeal cardiopulmonary resuscitation (E-CPR), and mechanical circulatory support (MCS). Featuring a

Five-Year GSA Contract Expands Raisbeck’s Footprint in Government Arena6.10.2022 16:21:00 CEST | Press release

Raisbeck Engineering, a leading provider of performance enhancement systems for business, commercial and military aircraft, today announced that it has been awarded a General Service Administration Multiple Award Schedule contract (MAS). The contract, which took effect September 30, 2022, is valid for five years with three five-year option periods. The GSA Schedule is significant in that it makes the company’s products accessible through a simplified buying process to state and federal government agencies, expanding the company’s footprint in the federal government marketplace. To qualify for GSA approval, the company went through a rigorous 18-month application process. Contractors selling through the GSA contract are carefully vetted beforehand and must have a proven track record within its industry. The GSA Multiple Award Schedule also provides a competitive advantage in the government sector since terms and conditions including pricing and warranties are previously agreed upon. “We

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom